Download FREE Report Sample
Download Free sampleValsartan, losartan, irbesartan and other ?-sartan? drugs are a class of medicines known as angiotensin II receptor blocker (ARBs) used to treat high blood pressure and heart failure.
Angiotensin II Receptor Blocker API Market contains market size and forecasts of Angiotensin II Receptor Blocker (ARBs) API in Global, including the following market information:
Global Angiotensin II Receptor Blocker (ARBs) API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Angiotensin II Receptor Blocker (ARBs) API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Valsartan Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Angiotensin II Receptor Blocker (ARBs) API include Teva Pharmaceutical, Aurobindo Pharma, Viatris, Tianyu Pharma, Huahai Pharmaceutical, Menovo, Rundu Pharma, Kinglyuan Pharmaceutical and Second Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Angiotensin II Receptor Blocker (ARBs) API companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angiotensin II Receptor Blocker (ARBs) API Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Angiotensin II Receptor Blocker (ARBs) API Market Segment Percentages, by Type, 2021 (%)
Valsartan
Irbesartan
Telmisartan
Losartan
Candesartan
Olmesartan
Others
Global Angiotensin II Receptor Blocker (ARBs) API Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Angiotensin II Receptor Blocker (ARBs) API Market Segment Percentages, by Application, 2021 (%)
Essential Hypertension
Secondary Hypertension
Global Angiotensin II Receptor Blocker (ARBs) API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Angiotensin II Receptor Blocker (ARBs) API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Angiotensin II Receptor Blocker (ARBs) API revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Angiotensin II Receptor Blocker (ARBs) API revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical
Aurobindo Pharma
Viatris
Tianyu Pharma
Huahai Pharmaceutical
Menovo
Rundu Pharma
Kinglyuan Pharmaceutical
Second Pharma
Apeloa
Jiangxi Synergy Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
